Cargando…

Frontal cortex chitinase and pentraxin neuroinflammatory alterations during the progression of Alzheimer’s disease

BACKGROUND: Chitinase 3-like 1 (CHI3L1), chitinase 3-like 2 (CHI3L2), and neuronal pentraxin II (NPTX2) are inflammatory biomarkers of Alzheimer’s disease (AD). Although studies have demonstrated that cerebrospinal fluid levels of these proteins are changed in AD, no studies have undertaken a detail...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moreno-Rodriguez, Marta, Perez, Sylvia E., Nadeem, Muhammad, Malek-Ahmadi, Michael, Mufson, Elliott J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025403/ https://www.ncbi.nlm.nih.gov/pubmed/32066474 http://dx.doi.org/10.1186/s12974-020-1723-x

Ejemplares similares

Neurogenesis and neuronal differentiation in the postnatal frontal cortex in Down syndrome
por: Utagawa, Emma C., et al.
Publicado: (2022)

Cerebellar Calcium-Binding Protein and Neurotrophin Receptor Defects in Down Syndrome and Alzheimer's Disease
por: Miguel, Jennifer C., et al.
Publicado: (2021)

Cognitive composite score association with Alzheimer’s disease plaque and tangle pathology
por: Malek-Ahmadi, Michael, et al.
Publicado: (2018)

Static and Dynamic Cognitive Reserve Proxy Measures: Interactions with Alzheimer’s Disease Neuropathology and Cognition
por: Malek-Ahmadi, Michael, et al.
Publicado: (2017)

Neuroinflammatory transcriptional programs induced in rhesus pre-frontal cortex white matter during acute SHIV infection
por: Hawes, Chase E., et al.
Publicado: (2022)

Neuroticism alters the transcriptome of the frontal cortex to contribute to the cognitive decline and onset of Alzheimer’s disease
por: De Jager, Céline H., et al.
Publicado: (2021)

Alterations of the Neuroinflammatory Markers IL-6 and TRAIL in Alzheimer's Disease
por: Wu, Ya-Ying, et al.
Publicado: (2015)

Estrogens regulate neuroinflammatory genes via estrogen receptors α and β in the frontal cortex of middle-aged female rats
por: Sárvári, Miklós, et al.
Publicado: (2011)

Transcriptome alterations in myotonic dystrophy frontal cortex
por: Otero, Brittney A., et al.
Publicado: (2021)

Altered abundances of human immunoglobulin M and immunoglobulin G subclasses in Alzheimer’s disease frontal cortex
por: Lekhraj, Rukmani, et al.
Publicado: (2022)

Locus coeruleus cellular and molecular pathology during the progression of Alzheimer’s disease
por: Kelly, Sarah C., et al.
Publicado: (2017)

Altered purinergic receptor expression in the frontal cortex in schizophrenia
por: Alnafisah, Rawan, et al.
Publicado: (2022)

Alteration of neural activity and neuroinflammatory factors in the insular cortex of mice with corneal neuropathic pain
por: Xu, Rui, et al.
Publicado: (2023)

Oxidative Damage and Antioxidant Response in Frontal Cortex of Demented and Nondemented Individuals with Alzheimer's Neuropathology
por: Fracassi, Anna, et al.
Publicado: (2021)

Neuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease
por: Uddin, Md. Sahab, et al.
Publicado: (2022)

Neuronal pentraxin receptor-1 is a new cerebrospinal fluid biomarker of Alzheimer’s disease progression
por: Begcevic, Ilijana, et al.
Publicado: (2018)

Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimer's disease brain
por: Rao, J S, et al.
Publicado: (2011)

Nerve Growth Factor Pathobiology During the Progression of Alzheimer’s Disease
por: Mufson, Elliott J., et al.
Publicado: (2019)

Gut Microbiota and Their Neuroinflammatory Implications in Alzheimer’s Disease
por: Giau, Vo Van, et al.
Publicado: (2018)

Long Pentraxin-3 Follows and Modulates Bladder Cancer Progression
por: Matarazzo, Sara, et al.
Publicado: (2019)

An interventional study of baicalin on neuronal pentraxin-1, neuronal pentraxin-2, and C-reactive protein in Alzheimer’s disease rat model
por: Zhao, Jing-Kun, et al.
Publicado: (2023)

Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients
por: Rao, J S, et al.
Publicado: (2012)

Apolipoprotein-E forms dimers in human frontal cortex and hippocampus
por: Elliott, David A, et al.
Publicado: (2010)

The Basic Characteristics of the Pentraxin Family and Their Functions in Tumor Progression
por: Wang, Zeyu, et al.
Publicado: (2020)

Alzheimer’s Disease: From Immune Homeostasis to Neuroinflammatory Condition
por: Princiotta Cariddi, Lucia, et al.
Publicado: (2022)

Neurogranin and Neuronal Pentraxin Receptor as Synaptic Dysfunction Biomarkers in Alzheimer’s Disease
por: Dulewicz, Maciej, et al.
Publicado: (2021)

ALTERED EXPRESSION OF GENES INVOLVED IN INFLAMMATION AND APOPTOSIS IN FRONTAL CORTEX IN MAJOR DEPRESSION
por: Shelton, RC, et al.
Publicado: (2010)

Alteration of astrocytes and Wnt/β-catenin signaling in the frontal cortex of autistic subjects
por: Cao, Fujiang, et al.
Publicado: (2012)

Phospholipid Profiles Are Selectively Altered in the Putamen and White Frontal Cortex of Huntington’s Disease
por: Phillips, Gabrielle R., et al.
Publicado: (2022)

Hypohydration alters pre-frontal cortex haemodynamics, but does not impair motor learning
por: Goodman, Stephen P. J., et al.
Publicado: (2022)

Histone post-translational modifications in frontal cortex from human donors with Alzheimer’s disease
por: Anderson, Kyle W., et al.
Publicado: (2015)

A multi-omic atlas of the human frontal cortex for aging and Alzheimer’s disease research
por: De Jager, Philip L., et al.
Publicado: (2018)

Metabolite Profile of Alzheimer’s Disease in the Frontal Cortex as Analyzed by HRMAS (1)H NMR
por: Zhang, Yuzhong, et al.
Publicado: (2019)

Neuregulin-1 (Nrg1) signaling has a preventive role and is altered in the frontal cortex under the pathological conditions of Alzheimer's disease
por: Jiang, Qiong, et al.
Publicado: (2016)

Chitinases and chitinase-like proteins as biomarkers in neurologic disorders
por: Pinteac, Rucsanda, et al.
Publicado: (2020)

Chitinases: An update
por: Hamid, Rifat, et al.
Publicado: (2013)

Post-mortem analysis of neuroinflammatory changes in human Alzheimer’s disease
por: Gomez-Nicola, Diego, et al.
Publicado: (2015)

Anti-neuroinflammatory Potential of Natural Products in Attenuation of Alzheimer's Disease
por: Shal, Bushra, et al.
Publicado: (2018)

Microglia in the Neuroinflammatory Pathogenesis of Alzheimer’s Disease and Related Therapeutic Targets
por: Cai, Yongle, et al.
Publicado: (2022)

Synbiotic-Derived Metabolites Reduce Neuroinflammatory Symptoms of Alzheimer's Disease
por: Pasinetti, Giulio
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_05jg0uq48df98lf1fdnilq7ba4